Immunoglobulin A (IgA) vasculitis nephritis (IgAVN) and IgA nephropathy (IgAN) share many pathological parallels and are viewed as related diseases by many groups. Current treatment guidelines remain vague, controversial, and without consensus, especially regarding the role of immunosuppressive medications. We present five cases of IgAVN encountered at our tertiary care center between 2016 and 2020, which were treated with different immunosuppression regimens. Infection was the leading cause of death in this series. These cases provide evidence that IgAVN should be distinguished from IgAN on a spectrum of IgA-associated glomerulonephritis. The outcomes presented herein suggest that the morbidity and systematic involvement IgAVN is greater than previously believed and that these substantial risks should be reflected in contemporary treatment guidelines.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Open Research

Data Availability

Data used to support the findings of the study are available from the corresponding author upon request, after removing the patient identifiers.

References

1 Sepahi M. A., Mubarak M., and Kellner J. S., Predicting renal outcomes in immunoglobulin A vasculitis nephritis; from ISKDC classification to oxford MEST-C classification, Journal of Renal Injury Prevention. (2020) 9, no. 1, https://doi.org/10.15171/jrip.2020.08.
10.15171/jrip.2020.08
Web of Science® Google Scholar
2 Nicoara O. and Twombley K., Immunoglobulin a nephropathy and immunoglobulin a vasculitis, Pediatric Clinics of North America. (2019) 66, no. 1, 101–110, https://doi.org/10.1016/j.pcl.2018.08.008, 2-s2.0-85056713513.
10.1016/j.pcl.2018.08.008
PubMed Web of Science® Google Scholar
3 Cattran D. C., Feehally J., Terence Cook H. et al., Kidney disease: improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis, Kidney International Supplements. (2012) 2, no. 2, 139–247.
Google Scholar
4 Ozen S., Marks S. D., Brogan P. et al., European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis—the SHARE initiative, Rheumatology. (2019) 58, no. 9, 1607–1616, https://doi.org/10.1093/rheumatology/kez041, 2-s2.0-85068836250.
10.1093/rheumatology/kez041
CAS PubMed Web of Science® Google Scholar
5 Jennette J. C., Falk R. J., Andrassy K. et al., Nomenclature of systemic vasculitides. Proposal of an international consensus conference, Arthritis & Rheumatism. (1994) 37, no. 2, 187–192, https://doi.org/10.1002/art.1780370206, 2-s2.0-0028158243.
10.1002/art.1780370206
CAS PubMed Web of Science® Google Scholar
6 Berger J. and Hinglais N., Les depots intercapillares d’IgA-IgG, Journal of Urology & Nephrology. (1968) 74, 694–695.
CAS Google Scholar
7 Larson A. R. and Granter S. R., Utility of immunofluorescence testing for vascular IgA in adult patients with leukocytoclastic vasculitis, American Journal of Clinical Pathology. (2014) 142, no. 3, 370–374, https://doi.org/10.1309/AJCPMB1A9QSWUJDY, 2-s2.0-84907174518.
10.1309/AJCPMB1A9QSWUJDY
PubMed Web of Science® Google Scholar
8 Pillebout E., Thervet E., Hill G., Alberti C., Vanhille P., and Nochy D., Henoch–Schönlein purpura in adults: outcome and prognostic factors, Journal of the American Society of Nephrology. (2002) 13, no. 5, 1271–1278, https://doi.org/10.1097/01.asn.0000013883.99976.22, 2-s2.0-0036232277.
10.1097/01.asn.0000013883.99976.22
PubMed Web of Science® Google Scholar
9 Audemard-Verger A., Terrier B., Dechartres A. et al., Characteristics and management of IgA vasculitis (Henoch-Schönlein) in adults: data from 260 patients included in a French multicenter retrospective survey, Arthritis & Rheumatology. (2017) 69, no. 9, 1862–1870, https://doi.org/10.1002/art.40178, 2-s2.0-85028443312.
10.1002/art.40178
CAS PubMed Web of Science® Google Scholar
10 Davin J.-C., Ten Berge I. J., and Weening J. J., What is the difference between IgA nephropathy and Henoch-Schönlein purpura nephritis?, Kidney International. (2001) 59, no. 3, 823–834, https://doi.org/10.1046/j.1523-1755.2001.059003823.x, 2-s2.0-0035091922.
10.1046/j.1523-1755.2001.059003823.x
CAS PubMed Web of Science® Google Scholar
11 Emancipator S. N., H. R. H. London, Primary and secondary forms of IgA nephritis and Schönlein–Henoch syndrome, Pathology of the Kidney. (1993) Little, Brown and Company, Toronto, Canada, 389–476.
Google Scholar
12 Hou J.-H., Le W.-B., Chen N. et al., Mycophenolate mofetil combined with prednisone versus full-dose prednisone in IgA nephropathy with active proliferative lesions: a randomized controlled trial, American Journal of Kidney Diseases. (2017) 69, no. 6, 788–795, https://doi.org/10.1053/j.ajkd.2016.11.027, 2-s2.0-85012911999.
10.1053/j.ajkd.2016.11.027
CAS PubMed Web of Science® Google Scholar
13 Ren P., Han F., Chen L. et al., The combination of mycophenolate mofetil with corticosteroids induces remission of Henoch-Schönlein purpura nephritis, American Journal of Nephrology. (2012) 36, no. 3, 271–277, https://doi.org/10.1159/000341914, 2-s2.0-84865838304.
10.1159/000341914
CAS PubMed Web of Science® Google Scholar
14 Lundberg S., Westergren E., Smolander J., and Bruchfeld A., B cell-depleting therapy with rituximab or of a tumumab in immunoglobulin A nephropathy or vasculitis with nephritis, Clinical Kidney Journal. (2017) 10, no. 1, 20–26, https://doi.org/10.1093/ckj/sfw106, 2-s2.0-85015933636.
10.1093/ckj/sfw106
PubMed Web of Science® Google Scholar
15 Fenoglio R., Naretto C., Basolo B. et al., Rituximab therapy for IgA-vasculitis with nephritis: a case series and review of the literature, Immunologic Research. (2017) 65, no. 1, 186–192, https://doi.org/10.1007/s12026-016-8827-5, 2-s2.0-84979296587.
10.1007/s12026-016-8827-5
CAS PubMed Web of Science® Google Scholar

Citing Literature

All articles

IgA Vasculitis Nephritis: A Case Series and Comparison of Treatment Guidelines

Abstract

Conflicts of Interest

Open Research

Data Availability

References

Citing Literature

Figures

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

IgA Vasculitis Nephritis: A Case Series and Comparison of Treatment Guidelines

Abstract

Conflicts of Interest

Open Research

Data Availability

References

Citing Literature

Figures

References

Related

Information